Datamonitor, Dec 2007, Pages: 50
Introduction Kosan Biosciences is a cancer therapeutics company engaged in advancing two new classes of anti-cancer agents through clinical development: heat s. ...
Life Science Analytics, March 2008, Pages: 15
Kosan Biosciences Inc.-Deals & Alliances Report contains the company?s contact information, business summary, company details, tables, graphs and listings of ...
Life Science Analytics, March 2008, Pages: 33
Kosan Biosciences Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic. ...
FactSet, Oct 2007
Business Update Call - Kosan Biosciences, Inc. - Earnings Transcript ... that have. 797709, Business Update Call - Kosan Biosciences, Inc. ...
Life Science Analytics, March 2008, Pages: 20
Kosan Biosciences Inc.-Financial Company Report contains the company?s contact information, details, business overview, shares information, stock performance ...
Annual Reports Service
56812, Kosan Biosciences Incorporated - KOSN - Annual Report, Research and Markets Annual Reports Service provides you with quick access to annual accounts and ...
ValuEngine, Inc., Oct 2007, Pages: 12
443243, (KOSN)KOSAN BIOSCIENCES INC - Quantitative Valuation Report, Advanced academic research that brings you superior investment strategies in an actionable ...
Global Reports, LLC, Dec 2007
601247, Kosan Biosciences Inc (KOSN) 2007 Annual Report, An Annual Report provides a detailed look at the financial results for the prior twelve months of ...
Life Science Analytics, March 2008, Pages: 58
330480, Kosan Biosciences Inc.-Detailed Product Pipeline, Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well ...
Global Reports, LLC, Dec 2005
390271, Kosan Biosciences Inc (KOSN) 2005 Annual Report, An Annual Report provides a detailed look at the financial results for the prior twelve months of ...
Global Industry Analysts, Inc., April 2009, Pages: 493
... companies including many key and niche players such as Amgen Inc., Avalon Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Kosan Biosciences, Inc., Celgene ...
Bizacumen Inc., Nov 2009, Pages: 347
... Research Investment and Education Act 34 Bayer and Cell Therapeutics Enter into Mutual Agreement 34 Bristol-Myers to Take Over Kosan Biosciences 35 Bristol and ...
Decision Resources, Inc., Nov 2006, Pages: 24
... Cubist Pharmaceuticals Genelex, Corp. Intergen, Inc. Kosan Biosciences, Inc. Medichem Life Sciences, Inc. Molecular Probes, Inc. ...